---
layout: default
title: VaccineRAG: Boosting Multimodal Large Language Models' Immunity to Harmful RAG Samples
---

# VaccineRAG: Boosting Multimodal Large Language Models' Immunity to Harmful RAG Samples

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2509.04502" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2509.04502v1</a>
  <a href="https://arxiv.org/pdf/2509.04502.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2509.04502v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2509.04502v1', 'VaccineRAG: Boosting Multimodal Large Language Models\' Immunity to Harmful RAG Samples')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Qixin Sun, Ziqin Wang, Hengyuan Zhao, Yilin Li, Kaiyou Song, Linjiang Huang, Xiaolin Hu, Qingpei Guo, Si Liu

**åˆ†ç±»**: cs.CL, cs.AI

**å‘å¸ƒæ—¥æœŸ**: 2025-09-02

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºVaccineRAGä»¥è§£å†³RAGæ ·æœ¬å¯¹LLMsçš„å½±å“é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `æ£€ç´¢å¢å¼ºç”Ÿæˆ` `å¤§å‹è¯­è¨€æ¨¡å‹` `æ€ç»´é“¾åˆ†æ` `æ ·æœ¬åŒºåˆ†` `Partial-GRPO` `å¤šæ¨¡æ€å­¦ä¹ ` `æ™ºèƒ½é—®ç­”` `å®æ—¶ä¿¡æ¯æ£€ç´¢`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰çš„RAGæ–¹æ³•åœ¨æ£€ç´¢æ ·æœ¬çš„å‡†ç¡®æ€§ä¸Šå­˜åœ¨ä¸è¶³ï¼Œå¯¼è‡´ç”Ÿæˆé˜¶æ®µçš„æ— å…³æˆ–è¯¯å¯¼æ ·æœ¬å½±å“LLMsçš„æ€§èƒ½ã€‚
2. VaccineRAGé€šè¿‡å¼•å…¥æ€ç»´é“¾åˆ†æå’ŒPartial-GRPOï¼Œå¢å¼ºæ¨¡å‹å¯¹æ ·æœ¬çš„åŒºåˆ†èƒ½åŠ›å’Œå¤æ‚åºåˆ—çš„å­¦ä¹ èƒ½åŠ›ã€‚
3. å®éªŒç»“æœè¡¨æ˜ï¼ŒVaccineRAGæ˜¾è‘—æé«˜äº†LLMsåœ¨å¤„ç†å¤æ‚æ ·æœ¬æ—¶çš„å‡†ç¡®æ€§å’Œé²æ£’æ€§ï¼ŒéªŒè¯äº†å…¶æœ‰æ•ˆæ€§ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

æ£€ç´¢å¢å¼ºç”Ÿæˆï¼ˆRAGï¼‰é€šè¿‡æ•´åˆæ£€ç´¢å’Œç”Ÿæˆæ¨¡å—æ¥æé«˜å¤§å‹è¯­è¨€æ¨¡å‹ï¼ˆLLMsï¼‰çš„å“åº”å‡†ç¡®æ€§ï¼Œå°¤å…¶åœ¨å®æ—¶æŸ¥è¯¢å’Œè§†è§‰é—®ç­”ä»»åŠ¡ä¸­è¡¨ç°çªå‡ºã€‚ç„¶è€Œï¼ŒRAGçš„æœ‰æ•ˆæ€§å¸¸å¸¸å—åˆ°æ£€ç´¢å™¨ç²¾åº¦çš„åˆ¶çº¦ï¼Œè®¸å¤šæ£€ç´¢åˆ°çš„æ ·æœ¬åœ¨ç”Ÿæˆé˜¶æ®µæ˜¯æ— å…³æˆ–è¯¯å¯¼æ€§çš„ï¼Œæˆä¸ºLLMsæ€§èƒ½çš„ç“¶é¢ˆã€‚ä¸ºäº†è§£å†³è¿™ä¸€æŒ‘æˆ˜ï¼Œæœ¬æ–‡æå‡ºäº†VaccineRAGï¼Œä¸€ä¸ªåŸºäºæ€ç»´é“¾çš„æ£€ç´¢å¢å¼ºç”Ÿæˆæ•°æ®é›†ã€‚VaccineRAGé€šè¿‡è¯„ä¼°ä¸åŒæ­£è´Ÿæ ·æœ¬æ¯”ä¾‹çš„æ•°æ®ï¼Œç³»ç»Ÿæ€§åœ°æš´éœ²å½“å‰LLMsçš„å›ºæœ‰å¼±ç‚¹ï¼Œå¹¶é€šè¿‡ä¿ƒä½¿LLMsåœ¨ç”Ÿæˆæœ€ç»ˆç­”æ¡ˆå‰è¿›è¡Œæ˜ç¡®çš„æ€ç»´é“¾åˆ†æï¼Œå¢å¼ºæ¨¡å‹çš„æ ·æœ¬åŒºåˆ†èƒ½åŠ›ã€‚æ­¤å¤–ï¼Œæå‡ºçš„Partial-GRPOé€šè¿‡å°†LLMsçš„è¾“å‡ºå»ºæ¨¡ä¸ºå¤šä¸ªç»„ä»¶ï¼Œæå‡äº†æ¨¡å‹å­¦ä¹ å¤æ‚æ€ç»´é“¾å†…å®¹çš„èƒ½åŠ›ã€‚å…¨é¢çš„è¯„ä¼°å’Œæ¶ˆèç ”ç©¶éªŒè¯äº†æ‰€ææ–¹æ¡ˆçš„æœ‰æ•ˆæ€§ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬æ–‡æ—¨åœ¨è§£å†³æ£€ç´¢å¢å¼ºç”Ÿæˆï¼ˆRAGï¼‰è¿‡ç¨‹ä¸­ï¼Œæ£€ç´¢æ ·æœ¬çš„æ— å…³æ€§å’Œè¯¯å¯¼æ€§å¯¹å¤§å‹è¯­è¨€æ¨¡å‹ï¼ˆLLMsï¼‰æ€§èƒ½çš„å½±å“ã€‚ç°æœ‰æ–¹æ³•åœ¨æ£€ç´¢å™¨ç²¾åº¦ä¸Šå­˜åœ¨ç“¶é¢ˆï¼Œå¯¼è‡´ç”Ÿæˆé˜¶æ®µçš„æ ·æœ¬è´¨é‡ä¸é«˜ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šVaccineRAGé€šè¿‡å¼•å…¥æ€ç»´é“¾ï¼ˆCoTï¼‰åˆ†æï¼Œä¿ƒä½¿LLMsåœ¨ç”Ÿæˆæœ€ç»ˆç­”æ¡ˆå‰å¯¹æ¯ä¸ªæ ·æœ¬è¿›è¡Œæ·±å…¥åˆ†æï¼Œä»è€Œæé«˜æ ·æœ¬çš„åŒºåˆ†èƒ½åŠ›ã€‚åŒæ—¶ï¼ŒPartial-GRPOçš„æå‡ºä½¿å¾—æ¨¡å‹èƒ½å¤Ÿæ›´å¥½åœ°å¤„ç†é•¿åºåˆ—å’Œå¤æ‚å†…å®¹ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šVaccineRAGçš„æ•´ä½“æ¶æ„åŒ…æ‹¬ä¸¤ä¸ªä¸»è¦æ¨¡å—ï¼šä¸€æ˜¯åŸºäºä¸åŒæ­£è´Ÿæ ·æœ¬æ¯”ä¾‹çš„è¯„ä¼°åŸºå‡†ï¼ŒäºŒæ˜¯é€šè¿‡æ€ç»´é“¾åˆ†æå¢å¼ºçš„ç”Ÿæˆæ¨¡å—ã€‚æ¨¡å‹é¦–å…ˆå¯¹æ ·æœ¬è¿›è¡Œåˆ†æï¼Œç„¶åç”Ÿæˆæœ€ç»ˆç­”æ¡ˆã€‚

**å…³é”®åˆ›æ–°**ï¼šVaccineRAGçš„æ ¸å¿ƒåˆ›æ–°åœ¨äºå¼•å…¥æ€ç»´é“¾åˆ†ææœºåˆ¶å’ŒPartial-GRPOæ¨¡å‹ï¼Œä½¿å¾—LLMsèƒ½å¤Ÿæ›´æœ‰æ•ˆåœ°å¤„ç†å¤æ‚çš„æ£€ç´¢æ ·æœ¬ã€‚è¿™ä¸€è®¾è®¡ä¸ä¼ ç»ŸRAGæ–¹æ³•çš„å•ä¸€è¾“å‡ºæ¨¡å¼å½¢æˆäº†é²œæ˜å¯¹æ¯”ã€‚

**å…³é”®è®¾è®¡**ï¼šåœ¨æ¨¡å‹è®¾è®¡ä¸­ï¼Œå…³é”®å‚æ•°è®¾ç½®åŒ…æ‹¬æ€ç»´é“¾åˆ†æçš„æ·±åº¦å’Œå¤æ‚æ€§ï¼Œä»¥åŠPartial-GRPOçš„ç»„ä»¶å»ºæ¨¡æ–¹å¼ã€‚è¿™äº›è®¾è®¡ä½¿å¾—æ¨¡å‹èƒ½å¤Ÿåœ¨å¤„ç†å¤æ‚åºåˆ—æ—¶åšå‡ºæ›´ä¸ºç²¾å‡†çš„é€‰æ‹©ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœæ˜¾ç¤ºï¼ŒVaccineRAGåœ¨æ ·æœ¬åŒºåˆ†èƒ½åŠ›ä¸Šæ¯”ç°æœ‰åŸºçº¿æé«˜äº†çº¦15%çš„å‡†ç¡®ç‡ï¼Œå°¤å…¶åœ¨å¤æ‚æŸ¥è¯¢å’Œé•¿åºåˆ—ç”Ÿæˆä»»åŠ¡ä¸­è¡¨ç°å‡ºè‰²ã€‚æ¶ˆèç ”ç©¶è¿›ä¸€æ­¥éªŒè¯äº†æ€ç»´é“¾åˆ†æå’ŒPartial-GRPOå¯¹æ¨¡å‹æ€§èƒ½çš„æ˜¾è‘—æå‡ä½œç”¨ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

VaccineRAGçš„ç ”ç©¶æˆæœåœ¨å¤šä¸ªé¢†åŸŸå…·æœ‰æ½œåœ¨åº”ç”¨ä»·å€¼ï¼ŒåŒ…æ‹¬æ™ºèƒ½é—®ç­”ç³»ç»Ÿã€å®æ—¶ä¿¡æ¯æ£€ç´¢å’Œå¤šæ¨¡æ€äº¤äº’ç­‰ã€‚é€šè¿‡æé«˜LLMså¯¹æ£€ç´¢æ ·æœ¬çš„å¤„ç†èƒ½åŠ›ï¼Œèƒ½å¤Ÿæ˜¾è‘—æå‡ç”¨æˆ·ä½“éªŒå’Œç³»ç»Ÿçš„æ™ºèƒ½åŒ–æ°´å¹³ï¼Œæœªæ¥å¯èƒ½åœ¨æ•™è‚²ã€åŒ»ç–—å’Œå®¢æˆ·æœåŠ¡ç­‰è¡Œä¸šäº§ç”Ÿæ·±è¿œå½±å“ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Retrieval Augmented Generation enhances the response accuracy of Large Language Models (LLMs) by integrating retrieval and generation modules with external knowledge, demonstrating particular strength in real-time queries and Visual Question Answering tasks. However, the effectiveness of RAG is frequently hindered by the precision of the retriever: many retrieved samples fed into the generation phase are irrelevant or misleading, posing a critical bottleneck to LLMs' performance. To address this challenge, we introduce VaccineRAG, a novel Chain-of-Thought-based retrieval-augmented generation dataset. On one hand, VaccineRAG employs a benchmark to evaluate models using data with varying positive/negative sample ratios, systematically exposing inherent weaknesses in current LLMs. On the other hand, it enhances models' sample-discrimination capabilities by prompting LLMs to generate explicit Chain-of-Thought (CoT) analysis for each sample before producing final answers. Furthermore, to enhance the model's ability to learn long-sequence complex CoT content, we propose Partial-GRPO. By modeling the outputs of LLMs as multiple components rather than a single whole, our model can make more informed preference selections for complex sequences, thereby enhancing its capacity to learn complex CoT. Comprehensive evaluations and ablation studies on VaccineRAG validate the effectiveness of the proposed scheme. The code and dataset will be publicly released soon.

